BCR and acute lymphoblastic leukemia: Genomic IKZF1plus (focal ΔIKZF1) was identified most commonly in patients with BCR::ABL1-like ALL with CRLF2r (60%), BCR::ABL1 ALL (30%), and BCR::ABL1-like ALL without CRLF2r (25%; Fig. 1A-C).